Sign in

NCT05272241Recruiting

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1500 (estimated)
First submitted
28 Feb 2022
Start date
6 May 2022
Primary completion date
May 2027
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Diseases
Asthma
NCT number
NCT05272241

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From 6 May 2022 to the primary completion date, May 2027
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
    • Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
    • Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.

Other

  • Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
  • Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up

Who the study is looking for

  • Participant is either:
    • At least 18 years old, willing and able to provide informed consent at the time of enrollment
    • Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
  • Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Children's Hospital Colorado: Allergy Program
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting
Boston Children's Hospital: Department of Immunology
Coordinator of this site? Confirm its status
BostonUnited StatesNot yet recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting
Cincinnati Children's Hospital Medical Center: Asthma Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesRecruiting
Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Coordinator of this site? Confirm its status
New YorkUnited StatesNot yet recruiting
Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site
Coordinator of this site? Confirm its status
Washington D.C.United StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.